Silva CM (October 2004). "Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis". Oncogene. 23 (48): 8017–23. doi:10.1038/sj.onc.1208159. PMID15489919. S2CID9420068.
Lim CP, Cao X (November 2006). "Structure, function, and regulation of STAT proteins". Molecular BioSystems. 2 (11): 536–50. doi:10.1039/B606246F. PMID17216035..
Levy DE, Loomis CA (October 2007). "STAT3 signaling and the hyper-IgE syndrome". The New England Journal of Medicine. 357 (16): 1655–8. doi:10.1056/NEJMe078197. PMID17881746.
Stasevich EM (April 2025). "Enhancer RNA from STAT3 locus affects temozolomide chemoresistance of glioblastoma cells". Gene. 944 149297. doi:10.1016/j.gene.2025.149297. PMID39889913.
Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, et al. (April 2001). "Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications. 283 (1): 179–87. Bibcode:2001BBRC..283..179M. doi:10.1006/bbrc.2001.4758. PMID11322786.
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al. (April 1999). "Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300". Science. 284 (5413): 479–82. Bibcode:1999Sci...284..479N. doi:10.1126/science.284.5413.479. PMID10205054.
Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES, et al. (June 2003). "Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation". Molecular Endocrinology. 17 (6): 1155–66. doi:10.1210/me.2002-0401. PMID12637586.
Kim J, Kim D, Chung J (2000). "Replication protein a 32 kDa subunit (RPA p32) binds the SH2 domain of STAT3 and regulates its transcriptional activity". Cell Biology International. 24 (7): 467–73. doi:10.1006/cbir.2000.0525. PMID10875894. S2CID23783745.
Thuya WL, Cao Y, Ho PC, Wong AL, Wang L, Zhou J, Nicot C, Goh BC. Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy. Cytokine Growth Factor Rev. 2025 Oct;85:26-42. doi:10.1016/j.cytogfr.2025.01.003PMID39893129
Uchihara Y, Ohe T, Mashino T, Kidokoro T, Tago K, Tamura H, et al. (December 2019). "N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties". Pharmacological Reports. 71 (6): 1067–1078. doi:10.1016/j.pharep.2019.05.021. PMID31627175. S2CID210983316.
Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, Kumer A, Tabrez S. STAT3 Signaling Pathway in Health and Disease. MedComm (2020). 2025 Mar 30;6(4):e70152. doi:10.1002/mco2.70152PMID40166646
Zhou H, Bai L, Xu R, Zhao Y, Chen J, McEachern D, Chinnaswamy K, Wen B, Dai L, Kumar P, Yang CY, Liu Z, Wang M, Liu L, Meagher JL, Yi H, Sun D, Stuckey JA, Wang S. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein. J Med Chem. 2019 Dec 26;62(24):11280-11300. doi:10.1021/acs.jmedchem.9b01530PMID31747516
Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, et al. (April 2001). "Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications. 283 (1): 179–87. Bibcode:2001BBRC..283..179M. doi:10.1006/bbrc.2001.4758. PMID11322786.
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al. (April 1999). "Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300". Science. 284 (5413): 479–82. Bibcode:1999Sci...284..479N. doi:10.1126/science.284.5413.479. PMID10205054.
Silva CM (October 2004). "Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis". Oncogene. 23 (48): 8017–23. doi:10.1038/sj.onc.1208159. PMID15489919. S2CID9420068.
Lim CP, Cao X (November 2006). "Structure, function, and regulation of STAT proteins". Molecular BioSystems. 2 (11): 536–50. doi:10.1039/B606246F. PMID17216035..
Levy DE, Loomis CA (October 2007). "STAT3 signaling and the hyper-IgE syndrome". The New England Journal of Medicine. 357 (16): 1655–8. doi:10.1056/NEJMe078197. PMID17881746.
Stasevich EM (April 2025). "Enhancer RNA from STAT3 locus affects temozolomide chemoresistance of glioblastoma cells". Gene. 944 149297. doi:10.1016/j.gene.2025.149297. PMID39889913.
Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, et al. (April 2001). "Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells". Biochemical and Biophysical Research Communications. 283 (1): 179–87. Bibcode:2001BBRC..283..179M. doi:10.1006/bbrc.2001.4758. PMID11322786.
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al. (April 1999). "Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300". Science. 284 (5413): 479–82. Bibcode:1999Sci...284..479N. doi:10.1126/science.284.5413.479. PMID10205054.
Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES, et al. (June 2003). "Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation". Molecular Endocrinology. 17 (6): 1155–66. doi:10.1210/me.2002-0401. PMID12637586.
Kim J, Kim D, Chung J (2000). "Replication protein a 32 kDa subunit (RPA p32) binds the SH2 domain of STAT3 and regulates its transcriptional activity". Cell Biology International. 24 (7): 467–73. doi:10.1006/cbir.2000.0525. PMID10875894. S2CID23783745.
Thuya WL, Cao Y, Ho PC, Wong AL, Wang L, Zhou J, Nicot C, Goh BC. Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy. Cytokine Growth Factor Rev. 2025 Oct;85:26-42. doi:10.1016/j.cytogfr.2025.01.003PMID39893129
Uchihara Y, Ohe T, Mashino T, Kidokoro T, Tago K, Tamura H, et al. (December 2019). "N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties". Pharmacological Reports. 71 (6): 1067–1078. doi:10.1016/j.pharep.2019.05.021. PMID31627175. S2CID210983316.
Samad MA, Ahmad I, Hasan A, Alhashmi MH, Ayub A, Al-Abbasi FA, Kumer A, Tabrez S. STAT3 Signaling Pathway in Health and Disease. MedComm (2020). 2025 Mar 30;6(4):e70152. doi:10.1002/mco2.70152PMID40166646
Zhou H, Bai L, Xu R, Zhao Y, Chen J, McEachern D, Chinnaswamy K, Wen B, Dai L, Kumar P, Yang CY, Liu Z, Wang M, Liu L, Meagher JL, Yi H, Sun D, Stuckey JA, Wang S. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein. J Med Chem. 2019 Dec 26;62(24):11280-11300. doi:10.1021/acs.jmedchem.9b01530PMID31747516
ncbi.nlm.nih.gov
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, et al. (April 1994). "Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway". Cell. 77 (1): 63–71. doi:10.1016/0092-8674(94)90235-6. PMID7512451. S2CID42211976.
Silva CM (October 2004). "Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis". Oncogene. 23 (48): 8017–23. doi:10.1038/sj.onc.1208159. PMID15489919. S2CID9420068.
Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F (August 2001). "Constitutive activation of STAT transcription factors in acute myelogenous leukemia". European Journal of Haematology. 67 (2): 63–71. doi:10.1034/j.1600-0609.2001.t01-1-00385.x. PMID11722592. S2CID38074766.
Kim J, Kim D, Chung J (2000). "Replication protein a 32 kDa subunit (RPA p32) binds the SH2 domain of STAT3 and regulates its transcriptional activity". Cell Biology International. 24 (7): 467–73. doi:10.1006/cbir.2000.0525. PMID10875894. S2CID23783745.
Uchihara Y, Ohe T, Mashino T, Kidokoro T, Tago K, Tamura H, et al. (December 2019). "N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties". Pharmacological Reports. 71 (6): 1067–1078. doi:10.1016/j.pharep.2019.05.021. PMID31627175. S2CID210983316.